Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome

Saito, Shigeru; Isshiki, Takaaki; Kimura, Takeshi; Ogawa, Hisao; Yokoi, Hiroyoshi; Nanto, Shinsuke; Takayama, Morimasa; Kitagawa, Kazuo; Nishikawa, Masakatsu; Miyazaki, Shunichi; Nakamura, Masato

doi:10.1253/circj.cj-13-1482

Public

Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome

Published in Circulation Journal • Jan 1, 2014

Authors:

Shigeru Saito

Takaaki Isshiki

Takeshi Kimura

Abstract

BACKGROUND: Prasugrel is an antiplatelet agent that shows more prompt, potent, and consistent platelet inhibition than clopidogrel. The objective of this study was to confirm the efficacy and safety of prasugrel at loading/maintenance doses of 20/3.75 mg. METHODS AND RESULTS: Japanese patients (n=1,...

Subject

Prasugrel

Clopidogrel

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!